Susquehanna International Group’s HUMANIGEN, INC. HGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-59,800
Closed -$106K 14481
2022
Q2
$106K Sell
59,800
-146,400
-71% -$329K ﹤0.01% 11428
2022
Q1
$621K Buy
206,200
+15,700
+8% +$42K ﹤0.01% 8379
2021
Q4
$709K Buy
190,500
+42,800
+29% +$250K ﹤0.01% 8219
2021
Q3
$876K Sell
147,700
-189,000
-56% -$2.66M ﹤0.01% 7912
2021
Q2
$5.85M Sell
336,700
-121,000
-26% -$2.21M ﹤0.01% 3737
2021
Q1
$8.74M Buy
457,700
+368,300
+412% +$6.72M ﹤0.01% 2990
2020
Q4
$1.56M Buy
+89,400
New +$1.07M ﹤0.01% 5642

Other funds holding HGEN

Susquehanna International Group's HGEN Position: Q2 2023 in Review

Susquehanna International Group sold out of HUMANIGEN, INC. (HGEN) in Q2 2023, closing a stake of 13,768 shares — an estimated $1.98K sold.

Susquehanna International Group first reported a position in HGEN in Q4 2020 and held it in 10 quarters. The position peaked at $7M in Q2 2021. 38 funds tracked by Wall St. Rank hold HGEN as of Q2 2023.

  • Susquehanna International Group reported no remaining HUMANIGEN, INC. position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 13,768 HUMANIGEN, INC. shares in Q2 2023, an estimated $1.98K.
  • Susquehanna International Group first reported a position in HUMANIGEN, INC. in Q4 2020 and held it in 10 quarters.
  • Susquehanna International Group's HUMANIGEN, INC. position peaked at $7M in Q2 2021.
  • 38 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.